These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12903649)

  • 61. LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others.
    Sirtori CR; Fumagalli R
    Atherosclerosis; 2006 May; 186(1):1-11. PubMed ID: 16310198
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Health benefits of high-density lipoproteins in preventing cardiovascular diseases.
    Berrougui H; Momo CN; Khalil A
    J Clin Lipidol; 2012; 6(6):524-33. PubMed ID: 23312048
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 64. Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL.
    Cao P; Pan H; Xiao T; Zhou T; Guo J; Su Z
    Int J Mol Sci; 2015 Jul; 16(8):17245-72. PubMed ID: 26225968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genaissance pharmaceuticals discovers genetic markers.
    Expert Rev Mol Diagn; 2002 May; 2(3):203-4. PubMed ID: 12050857
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-Density Lipoprotein Processing and Premature Cardiovascular Disease.
    Rosales C; Gillard BK; Gotto AM; Pownall HJ
    Methodist Debakey Cardiovasc J; 2015; 11(3):181-5. PubMed ID: 26634027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cholesterol-absorbed in thought.
    Tietge UJ
    Curr Opin Lipidol; 2016 Apr; 27(2):202-3. PubMed ID: 26959709
    [No Abstract]   [Full Text] [Related]  

  • 69. Dissociating HDL cholesterol from cardiovascular risk.
    Hausenloy DJ; Opie L; Yellon DM
    Lancet; 2010 Jul; 376(9738):305-6. PubMed ID: 20655104
    [No Abstract]   [Full Text] [Related]  

  • 70. Update in preventive medicine.
    Merenstein JH
    Ann Intern Med; 2000 May; 132(10):844-5. PubMed ID: 10819718
    [No Abstract]   [Full Text] [Related]  

  • 71. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Significance of HDL cholesterol increase for the risk reduction. Methods of intervention. recommendations of experts].
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II5-12. PubMed ID: 19813328
    [No Abstract]   [Full Text] [Related]  

  • 74. [Medical treatment of atherosclerosis].
    Schmermund A; Wieneke H; Erbel R
    Med Monatsschr Pharm; 2005 Sep; 28(9):300-8. PubMed ID: 16163880
    [No Abstract]   [Full Text] [Related]  

  • 75. [Insulin-dependent diabetes and lipoprotein metabolism].
    Berthezène F; Perrot L; Valentin C; Sautot G
    Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
    [No Abstract]   [Full Text] [Related]  

  • 76. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study.
    van den Bogaard B; van den Born BJ; Fayyad R; Waters DD; DeMicco DA; LaRosa JC; Kastelein JJ; Holme I;
    Eur J Clin Invest; 2011 Feb; 41(2):134-42. PubMed ID: 20868450
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human genetics of HDL: Insight into particle metabolism and function.
    Brunham LR; Hayden MR
    Prog Lipid Res; 2015 Apr; 58():14-25. PubMed ID: 25601427
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-high-density lipoprotein cholesterol: current status as cardiovascular marker.
    Verbeek R; Hovingh GK; Boekholdt SM
    Curr Opin Lipidol; 2015 Dec; 26(6):502-10. PubMed ID: 26780004
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-density lipoprotein cholesterol and the role of statins.
    Chong PH; Kezele R; Franklin C
    Circ J; 2002 Nov; 66(11):1037-44. PubMed ID: 12419937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.